IP Library Granted Patent US 9,896,442
Granted Patent B2
US 9,896,442 · App. 15/088,815 · Granted Feb 20, 2018

Antifungal treatment

Inventors: Bruce Steven Klein (Madison, WI); Brad Mark Tebbets (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C07D417/12A01N43/08A01N43/653A01N43/78A01N43/82A61K31/341A61K31/345A61K31/4196A61K31/427A61K31/433C07D307/66C07D307/71
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,896,442
App. No.
15/088,815
Granted
Feb 20, 2018
Kind
B2
Abstract

A method of treating or preventing fungal infection, which includes identifying a plant or animal having a fungal infection and administering an effective amount of an anti-fungal composition to the plant or animal to reduce the fungal infection. In a preferred form of the present invention, the antifungal composition is compound 13 or 33 and is combined with an azole compound, such as fluconazole.

Claims (19)

1. A method for treating fungal infection, comprising:

(a) identifying a plant or animal having a fungal infection; and

(b) administering an effective amount of an anti-fungal compound to the plant or animal, wherein the amount is effective to reduce the fungal infection and wherein the compound is represented by formula (IV),

wherein is an alkane, alkene, or alkyne, and R 5 is selected from the group consisting of formulas (V), (VI), (VII), and (VIII):

or a salt, solvate or hydrate thereof.

2. The method of claim 1 wherein the histidine kinase-dependent anti-fungal compound is:

or a salt, solvate or hydrate thereof.

3. The method of claim 1 additionally comprising administering an amount of an azole compound effective to reduce fungal infection.

4. The method of claim 3 wherein the azole is fluconazole.

5. The method of claim 1 , wherein the compound is a histidine kinase-dependent antifungal compound.

6. The method of claim 5 , wherein the histidine kinase is Drk1.

7. A method for preventing a fungal infection, comprising:

administering an effective amount of a composition comprising a compound of formula (IV) to a plant or animal, wherein the amount is effective to prevent a fungal infection,

wherein is an alkane, alkene, or alkyne, and R 5 is selected from the group consisting of formulas (V), (VI), (VII), and (VIII):

or a salt, solvate or hydrate thereof.

8. The method of claim 7 wherein the compound is:

or a salt, solvate or hydrate thereof.

9. The method of claim 7 additionally comprising administering an amount of an azole compound effective to reduce fungal infection.

10. The method of claim 7 wherein the azole is fluconazole.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 16, 2018
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046171/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2017
From: TEBBETS, BRAD; KLEIN, BRUCE
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 041694/0717 →
Continuity (4)
Continuation 14029069 · Sep 17, 2013
Division 13089704 · Apr 19, 2011
Provisional Application 61325548 · Apr 19, 2010
Related Publication 20160289224A1 · Oct 6, 2016